TDP-43 protein interactome informs about perturbed canonical pathways and may help develop personalized medicine

Benjamin R Helmold1, Kate E Pauss1, P Hande Ozdinler2

  • 1Department of Neurology, Feinberg School of Medicine, Northwestern University, 303 E. Chicago Ave, Chicago, IL, 60611, USA.

Drug Discovery Today
|September 15, 2023
PubMed

Insights

Transactive response DNA binding protein of 43 kDa (TDP-43) pathology is linked to protein interactions. Targeting these interactions and cellular pathways may enable personalized medicine for neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Transactive response DNA binding protein of 43 kDa (TDP-43) pathology is prevalent in neurodegenerative diseases.
  • Protein-protein interactions involving TDP-43 are implicated in disease pathogenesis.
  • Understanding these interactions is crucial for developing effective treatments.

Purpose of the Study:

  • To identify TDP-43-binding proteins across different domains.
  • To correlate TDP-43 interactions with specific canonical cellular pathways.
  • To explore potential therapeutic targets for TDP-43-related neurodegeneration.

Main Methods:

  • Investigated TDP-43 protein interactions within distinct cellular domains.
  • Utilized pathway analysis to link protein interactions to cellular mechanisms.
  • Reviewed existing compounds for their potential to modulate identified pathways.

Main Results:

  • Identified key cellular events associated with TDP-43 binding proteins in specific domains.
  • Correlated TDP-43 interactions with relevant canonical pathways.
  • Highlighted previously identified compounds capable of modulating these pathways.

Conclusions:

  • TDP-43 protein interactions play a significant role in neurodegenerative pathology.
  • Perturbed cellular pathways offer potential targets for therapeutic intervention.
  • Personalized medicine approaches focusing on cellular mechanisms are a promising future direction.